What date does Spero Therapeutics's (SPRO) report Earnings

Report Date Period Ending Zacks Consensus Estimate Earnings ESP; 11/11/2024 ... For their last quarter, Spero Therapeutics (SPRO) reported earnings of -$0.33 per share, beating the Zacks …

CouponFollow Extension

$0.33
OFF

What Date Does Spero Therapeutics's (SPRO) Report Earnings

6 days from now

Report Date Period Ending Zacks Consensus Estimate Earnings ESP; 11/11/2024 ... For their last quarter, Spero Therapeutics (SPRO) reported earnings of -$0.33 per share, beating the Zacks …

zacks.com

$7.67
OFF

What To Expect From Spero Therapeutics Inc (SPRO) Q3 2024 …

6 days from now

Nov 13, 2024 · Spero Therapeutics Inc (NASDAQ:SPRO) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 2024 revenue is $7.67 million, and the …

yahoo.com

$0.33
OFF

Spero Therapeutics (SPRO) To Release Earnings On Thursday

6 days from now

Nov 8, 2024 · Spero Therapeutics (NASDAQ:SPRO - Get Free Report) last issued its quarterly earnings results on Monday, August 5th.The company reported ($0.33) EPS for the quarter, …

marketbeat.com

41%
OFF

Spero Therapeutics Inc Earnings Dates, Reports, Calls

6 days from now

The latest SPRO earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$17.9M, up 41% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, SPRO …

wallstreetzen.com

2%
OFF

Spero Therapeutics Earnings Dates, Upcoming And Historical

6 days from now

The company held a conference call for investors at 4:30 PM eastern on the same day. SPRO shares declined -5.2% the day following the earnings announcement to close at 1.27. …

marketchameleon.com

33%
OFF

Spero Therapeutics, Inc. (SPRO) Q4 Earnings And Revenues Top …

6 days from now

Mar 13, 2024 · Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 633.33% and 278.99%, respectively, for the quarter ended December 2023. ... This quarterly …

yahoo.com

$0.32
OFF

Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue …

6 days from now

Nov 14, 2024 · Spero Therapeutics, Inc. (SPRO Quick Quote SPRO - Free Report) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of …

zacks.com

44%
OFF

Spero Therapeutics Revenue 2015-2024 - Stock Analysis

6 days from now

Nov 12, 2024 · Spero Therapeutics had revenue of $10.20M in the quarter ending June 30, 2024, with 275.44% growth. ... 3 months ago - Spero Therapeutics, Inc. (SPRO) Q2 2024 Earnings …

stockanalysis.com

$0.55
OFF

Spero Therapeutics, Inc. (SPRO) Q4 Earnings And Revenues Beat

6 days from now

Mar 30, 2023 · Spero Therapeutics, Inc. (SPRO) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of a loss of $0.40 per share. This compares to …

nasdaq.com

1%
OFF

JAZZ Secures FDA Approval For Ziihera In Biliary Tract Cancer

6 days from now

1 day ago · Year to date, shares of Spero Therapeutics have lost 21.1%. Spero Therapeutics’ earnings beat estimates in two of the trailing four quarters and missed the mark in the other …

nasdaq.com

FAQs about What date does Spero Therapeutics's (SPRO) report Earnings Coupon?

How much did Spero Therapeutics (Spro) earn?

Spero Therapeutics, Inc. (SPRO) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of a loss of $0.18 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 633.33%. ...

How did Spero Therapeutics (Spro) perform in the quarter?

Spero Therapeutics, Inc. (NASDAQ:SPRO) reported earnings for the last quarter on August 10th. The company posted earnings per share (EPS) of ($0.23), which was $0.06 better than the consensus estimate of ($0.29). Spero Therapeutics had revenue of $2.72 million for the quarter, exceeding the consensus estimate of $2.20 million. ...

What time does Spero Therapeutics (Spro) call a conference call?

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2024 Earnings Conference Call August 5, 2024 4:30 AM ET Company Participants Shai Biran - Senior Director Investor Relations Sath Shukla - Chief Executive Of... ...

Should I buy Spero Therapeutics stock at $37?

Raghuram Selvaraju of H.C. Wainwright maintains a Buy rating on Spero Therapeutics (NASDAQ: SPRO) stock, but lowered the price target to $37 from $43. ...

What is Spero Therapeutics?

Spero Therapeutics is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. Founded in 2013, it focuses on treatments with a novel therapeutic approach to treat multi-drug resistant and life-threatening bacterial infections and rare diseases. ...

Why did Spero Therapeutics suspend its spr720 development activities?

In its latest earnings report, Spero Therapeutics highlighted the suspension of its SPR720 development activities due to insufficient efficacy in a Phase 2a study and potential safety concerns. ...